PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION
Objective. Pharmacoeconomic analysis of the use of combinations of antihypertensive drugs were olmesartan/lercanidipine and zofenopril/lercanidipine in patients with essential hypertension II-III stage.Materials and methods. The authors performed prospective randomized uncontrolled study. Were exami...
Saved in:
Main Authors: | D. S. Kaskaeva, M. M. Petrova, O. V. Zimnitskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2017-03-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/162 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine
by: O. V. Zimnitskaya, et al.
Published: (2016-11-01) -
Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital
by: L. N. Sheikhmambetova, et al.
Published: (2021-10-01) -
PHARMACOECONOMIC ANALYSIS OF OLMESARTAN THERAPY IN THE INDIVIDUAL–LEVEL MANAGEMENT OF ARTERIAL HYPERTENSION
by: S. G. Gorokhova, et al.
Published: (2012-08-01) -
Drug Cost Optimization Using Evidence-Based Decision Support Systems
by: A. V. Kryukov, et al.
Published: (2023-12-01) -
ABC END VEN ANALYSYS OF COSTS FOR MEDICINE SAND MEDICAL TREATMENT COSTS PATIENT
by: M. A. Shapovalova, et al.
Published: (2015-03-01)